Beyond the Scale: Psychological and Behavioural Considerations Following GLP-1 Receptor Agonist Treatment Discontinuation
Diabetes, obesity & metabolism · 2026 Nov 3 · Newman AK, Billings LK et
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 2 19:00 ETSource: Diabetes, obesity & metabolism
From the source
Read at pubmed.ncbi.nlm.nih.govBeyond the Scale: Psychological and Behavioural Considerations Following GLP-1 Receptor Agonist Treatment Discontinuation
Diabetes, obesity & metabolism · 2026 Nov 3 · Newman AK, Billings LK et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42978233/
